Evidence map›Paper›PMID 40843068›Full record

ArticleFrontiers in pediatrics2025

Development of the EPO-Score - a multivariable tool to predict adverse outcome in infants with perinatal asphyxia undergoing therapeutic hypothermia - a retrospective study.

Adriana van der Donk, Maria Schleier, Alisa Bär, Linda Mulzer, Regina Trollmann, Stephanie Schuessler, Steven Hébert, Gregor Hanslik, Joachim Woelfle, Heiko Reutter and 1 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adriana van der DonkDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Maria SchleierDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Alisa BärDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Linda MulzerDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Regina TrollmannDepartment of Pediatrics, Pediatric Neurology, University Hospital Erlangen, Erlangen, Germany.
Stephanie SchuesslerDepartment of Pediatrics, Pediatric Neurology, University Hospital Erlangen, Erlangen, Germany.
Steven HébertDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Gregor HanslikDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Joachim WoelfleDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Heiko ReutterDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.
Patrick MorhartDivision of Neonatology and Pediatric Intensive Care, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Early outcome prediction in neonates with perinatal asphyxia receiving therapeutic hypothermia (TH) remains difficult. Although several studies have explored prognostic markers and proposed scoring systems, none of these tools has been adopted for routine bedside use to date. The present retrospective study aimed to design an early prognostic outcome score (EPO-Score). The score serves to identify patients at discharge, predicting severe adverse outcomes according to the Griffiths Mental Development Scales (GMDS) with one year. Methods: Perinatal data was collected from 44 infants with perinatal asphyxia who had received therapeutic hypothermia between 2010 and 2020 at the University Hospital Erlangen, Germany. 27 predictive variables were analyzed regarding their prognostic significance. Analysis showed significant correlations between 15 variables and their outcome. Outcome at one year was classified as favorable (GMDS DQ > 78) or severe adverse (DQ < 78, cerebral palsy, or death). We combined related variables into four indices: systemic injury, neurologic, liver and renal damage. A forward-looking step-by-step analysis revealed a model, explaining 62.1% of the variance in the outcome (R Results: A total of 32 (out of 44) infants met the inclusion criteria. 25 infants experienced a favorable outcome, 7 infants a severe adverse outcome. The EPO-Score integrates eight routine predictors. Average EPO-Score among all infants was 11 points (range 0-24). The EPO-Score showed significant association with the developmental outcome at one year of age (R Conclusion: EPO-Score underlines the correlation between the severity of early multi-organ involvement and severe adverse outcome, demonstrating a high predictive value within our study population. Early identification of patients with severe adverse outcome is important for optimizing neurodevelopmental therapies and providing family support. Nevertheless, external validation is required before the score can be implemented in routine clinical care.

Indexed as

asphyxiacerebral palsyGriffiths mental development scaleshypothermia treatmenthypoxic ischemic encephalopathyneonatal outcome

Identifiers

PMID40843068
PMCPMC12364892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.